Navigation Links
VioQuest to Present Data on Oncology Compounds VQD-002 and Lenocta(TM) at AACR-NCI-EORTC International Meeting
Date:10/19/2007

BASKING RIDGE, N.J., Oct. 19 /PRNewswire-FirstCall/ -- VioQuest Pharmaceuticals (OTC Bulletin Board: VQPH), a New Jersey-based biopharmaceutical company focused on acquiring, developing and commercializing targeted cancer therapeutics, announced today that it will be presenting data in poster presentations pertaining to VQD-002 (TCN-PM) and Lenocta(TM) (SSG) at the "Molecular Targets and Cancer Therapeutics" International Conference sponsored by the American Association for Cancer Research (AACR), the National Cancer Institute (NCI), and the European Organization for Research and Treatment of Cancer (EORTC) taking place October 22-26, 2007 at the Moscone Convention Center West in San Francisco, CA.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070117/NYW085LOGO )

VQD-002:

Abstract Number B71 titled, "Phase I pharmacokinetic and pharmacodynamic study of the inhibitor of activation of AKT (p-Akt), triciribine phosphate monohydrate (TCN-PM), in solid malignancies."

Session Title: Poster Session B

Session Subtitle: Clinical Trials

Session Date: Wednesday, October 24, 2007, 12:30 P.M. PDT

Session Time: 12:30-2:30 P.M. and 5:30-7:30 P.M. PDT

Session Location: Exhibit Hall, First Floor, Moscone Convention

Center West

Lenocta(TM)

Abstract Number B89 titled, "Phase I Dose Escalation Study of Sodium Stibogluconate (SSG), a protein tyrosine phosphatase inhibitor - in Combination with Interferon-alpha for patients with solid tumors."

Session Title: Poster Session B

Session Subtitle: Clinical Trials

Session Date: Wednesday, October 24, 2007, 12:30 P.M. PDT

Session Time: 12:30-2:30 PM and 5:30-7:30 P.M. PDT

Session Location: Exhibit Hall, First Floor, Moscone Convention


'/>"/>

SOURCE VioQuest Pharmaceuticals
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Surgeons Presented Guidelines For Postoperative Atrial Fibrillation
2. Researchers Present Ways To Reduce The Risk Of Dementia
3. Researchers Present Data Regarding The Efficiency Of Herbs
4. Critically Ill Patients More At Risk Of Infection If Glucose Is Present In Their Lung Secretions
5. Ovarian Cancer Presents ‘Target Symptoms’ Six Months Before Diagnosi
6. Drug Reactions First Present Themselves In The Mouth
7. Reminiscing Into The Past Makes You Dissatisfied With The Present
8. Living In The Past Indicates Dissatisfaction With Present
9. Movies Represent Coma In A Wrong Way
10. Onchocerciasis: Presentation And Treatment
11. Researchers Warn That Routine Physical Examination Could Miss Breech Presentation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... VA (PRWEB) , ... September 03, 2015 , ... ... the Spouse/Caregiver Scholarship applications are open for spring 2016. Scholarships are awarded two ... members. Hope For The Warriors® is a national nonprofit dedicated to restoring a ...
(Date:9/3/2015)... ... September 03, 2015 , ... Advice columnist, professional ... her debut book, “Stop Wasting Your Time Blaming Others for Your Life.” , ... guide to overcoming life’s obstacles by taking full responsibility for one’s life shares ...
(Date:9/3/2015)... ... September 03, 2015 , ... ... comprehensive eating disorder treatment for adults and adolescents struggling with anorexia, bulimia, ... has joined the medical treatment team. As a Staff Psychiatrist, Dr. Calinoiu ...
(Date:9/3/2015)... ... 2015 , ... As a result of the Patient Protection ... insurance plans, more employers are moving to a self-funded model for pharmacy plans, ... United Benefit Advisors (UBA) Health Plan Survey. , UBA’s survey, the nation’s largest ...
(Date:9/3/2015)... ... 03, 2015 , ... ProScrub is a set of automated tools that allow ... custom speed effects without the use of keyframes. Utilize ProScrub's powerful sliders to ... are perfect complements to energetic video productions. ProScrub is a Final Cut ...
Breaking Medicine News(10 mins):Health News:Hope For The Warriors Spouse/Caregiver Scholarships Now Open for Spring 2016 2Health News:Popular Advice Columnist Shares Her Path to Overcoming Personal Trials in Debut Book 2Health News:Popular Advice Columnist Shares Her Path to Overcoming Personal Trials in Debut Book 3Health News:Ileana Calinoiu, MD Joins Eating Recovery Center of Washington Medical Treatment Team 2Health News:Ileana Calinoiu, MD Joins Eating Recovery Center of Washington Medical Treatment Team 3Health News:Self-Funded Pharmacy Plans Becoming More Popular Among Large Employers 2Health News:Self-Funded Pharmacy Plans Becoming More Popular Among Large Employers 3Health News:Self-Funded Pharmacy Plans Becoming More Popular Among Large Employers 4Health News:FCPX Effects Developer Releases ProScrub for Final Cut Pro X 2
... , , SAN RAMON, Calif., ... who plays Dwight Schrute on NBC,s hit show The Office, ... night, August 15, at the home of Gouya and Payam Zamani, ... Mona Foundation, a non-profit organization that supports social and economic development ...
... juice to combat urinary tract infections is ,unsatisfactory and ... day..." Not all medical problems require a state-of-the-art solution, ... from the corner shop could treat a widespread and ... touted as a simple solution for urinary tract infections, ...
... , , , ... a leading national law firm in the fight against mesothelioma and ... foremost trial attorneys in the country, has joined the firm as ... of asbestos cancer cases since the late 1970s. He has successfully ...
... , , , ... sanofi-aventis U.S. announced today that the U.S. Food and Drug ... six months and older for the relief of symptoms of ... hives) and for children age two years and older for ...
... Avacor ( ) P r oducts LLC ... in the hair re-growth industry, has recently teamed up with two charitable organizations, ... ), and Team Continuum ( http://www.teamcontinuum.net ). ... fighting cancer as well as to help find new ways to fight this prolific ...
... , ST. LOUIS, Aug. 24 ... the herbicide Atrazine have attorney and clean water advocate Steve ... transparency and accountability for the herbicide,s manufacturers. , , ... in the New York Times and the Peoria Journal Star ...
Cached Medicine News:Health News:Rainn Wilson ('Dwight' on The Office) Joins Reply.com at Fundraiser for Mona Foundation 2Health News:Decorated Trial Attorney Conard Metcalf Joins Simmons Firm as 'Of Counsel' 2Health News:Decorated Trial Attorney Conard Metcalf Joins Simmons Firm as 'Of Counsel' 3Health News:FDA Approves XYZAL(R) For Use In Children Age Six Months And Older For The Relief Of Perennial Allergic Rhinitis And Chronic Idiopathic Urticaria 2Health News:FDA Approves XYZAL(R) For Use In Children Age Six Months And Older For The Relief Of Perennial Allergic Rhinitis And Chronic Idiopathic Urticaria 3Health News:FDA Approves XYZAL(R) For Use In Children Age Six Months And Older For The Relief Of Perennial Allergic Rhinitis And Chronic Idiopathic Urticaria 4Health News:FDA Approves XYZAL(R) For Use In Children Age Six Months And Older For The Relief Of Perennial Allergic Rhinitis And Chronic Idiopathic Urticaria 5Health News:FDA Approves XYZAL(R) For Use In Children Age Six Months And Older For The Relief Of Perennial Allergic Rhinitis And Chronic Idiopathic Urticaria 6Health News:FDA Approves XYZAL(R) For Use In Children Age Six Months And Older For The Relief Of Perennial Allergic Rhinitis And Chronic Idiopathic Urticaria 7Health News:FDA Approves XYZAL(R) For Use In Children Age Six Months And Older For The Relief Of Perennial Allergic Rhinitis And Chronic Idiopathic Urticaria 8Health News:FDA Approves XYZAL(R) For Use In Children Age Six Months And Older For The Relief Of Perennial Allergic Rhinitis And Chronic Idiopathic Urticaria 9Health News:FDA Approves XYZAL(R) For Use In Children Age Six Months And Older For The Relief Of Perennial Allergic Rhinitis And Chronic Idiopathic Urticaria 10Health News:Avacor(R), a Leader in Hair Regrowth, Announces Charities of Choice: Team Continuum and City of Hope 2Health News:Korein Tillery: Is Time Running Out for the Manufacturers of the Herbicide Atrazine? 2Health News:Korein Tillery: Is Time Running Out for the Manufacturers of the Herbicide Atrazine? 3
(Date:9/3/2015)... Sep. 03, 2015 Research ... of the "Investigation Report on China,s Raloxifene Market, ... to the statistics, over 200 million people suffer from ... above in China , 50% have ... 30%-50% among women aged 60 and above. Raloxifene ...
(Date:9/3/2015)... -- China,s startup business ExtantFuture ... wearable medical device that can continuously monitor the fetal ... guidance for pregnant women. The device will debut on ... measures 4 centimeters in diameter, is as thin as ... an Apple earphone cord. The small and compact device ...
(Date:9/3/2015)... Sept. 3, 2015 HeartWare International, Inc ... less invasive, miniaturized circulatory support technologies that are revolutionizing ... its President and Chief Executive Officer, Doug Godshall ... Fargo Healthcare Conference at 8:50 a.m. ET on Wednesday, ... 2015 at The Hyatt Regency, Boston ...
Breaking Medicine Technology:Investigation Report on China's Raloxifene Market, 2015-2019 2Modoo to Debut at Kickstarter: First Device on the Market that Enables Continuous Monitoring of Fetal Heart Rate and Fetal Movement 2HeartWare Presentation At The 2015 Wells Fargo Healthcare Conference To Be Webcast 2
... 28 Parents may be giving their children ... research being presented this week at Research Forum ... American College of Emergency Physicians.  Two studies are ... Medication Dosing Cups Are Inaccurate" and "Do Parents ...
... YORK, Sept. 27 Pfizer Inc. announced today ... trial evaluating SUTENT® (sunitinib malate) in combination with ... (CRPC) that had progressed despite treatment with a ... an independent Data Monitoring Committee (DMC) found that ...
Cached Medicine Technology:Warnings Re: Over-the-Counter Medication for Children: Less is More 2Pfizer Discontinues Phase 3 Trial of SUTENT® in Advanced Castration-Resistant Prostate Cancer 2Pfizer Discontinues Phase 3 Trial of SUTENT® in Advanced Castration-Resistant Prostate Cancer 3Pfizer Discontinues Phase 3 Trial of SUTENT® in Advanced Castration-Resistant Prostate Cancer 4
The proximally modular S-ROM Total Hip System provides custom capability at non-custom prices and is competitive with conventional porous coated systems....
The proximally modular S-ROM Total Hip System provides custom capability at non-custom prices and is competitive with conventional porous coated systems....
Severe revision options for the knee and hip...
The Natural-Hip combines the surgical simplicity of a straight stem with many of the best features of an anatomic stem....
Medicine Products: